Exclusive of VAT Out of stock Original price was: ..24.000.Current price is: ..20.000
These results guide whether you respond optimally to semaglutide monotherapy, tirzepatide monotherapy, or PlexusDx GLP-Squared dual-compound protocolpersonalizing your medication to your genetic predisposition for maximum weight-loss outcomes
View at Publisher | View at Google Scholar Li Y et al
#GLP1 #MetabolicHealth #LifestyleMedicine #ObesityMedicine #ContinuousCare #BehaviorChange www.cyglera.com Robert Graham, MD, MPH, Chef, Hunain Mehmood, Sean Locke, Jacqueline Thompson, MS, RD, CDCES, MES, Beth Machnica MPH, MS, RDN, CDN, WELL AP, Daniel Bordenave, Cyglera - Lifestyle Medicine-as-a-Service To view or add a comment, sign in One important point here is that sustainable metabolic health outcomes often depend on far more than access to treatment alone